PatternsRadar
Sign in

KPLKwality Pharmaceuticals Limited

NSE
Full chart
3,745.00INR+100.80 (+2.77%)Close · 6 Oct 2026
—Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹3,886 CrMarket cap
—P/E (TTM)
54.9%Delivery

Growth

CSV
Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ—
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open3,644.20
Day range3,580.50 – 3,777.00
52-week range—
From 52w high—
RSI (14)59.5
ATR (14)185.79
Volume29.3K
Avg volume (20D)48.5K
Rel volume0.60×
Volatility (1Y)58.5%
Turnover₹11.0Cr
SMA 50 / 2003,309.74 / —

Delivery percentage

Latest · 6 Oct 202654.9%
20-day avg40.7%
1-year avg47.3%
Percentile (own history)78th
Range17.1–76.3%
Sessions117

Over the last 20 sessions KPL settled 40.7% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 47.3%, so recent sessions are running 6.6 points lower than usual.

What delivery percentage measuresScan the whole market on delivery

Performance returns

CSV
1D1W1M3M6M1Y
Price+2.77%+4.70%+11.73%+46.83%——

Valuation

CSV
Market cap₹3,886 Cr
P/E (TTM)—
EPS (TTM)—
Shares outstanding—
Listed20 Apr 2026

Ownership

Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—

KPL at a glance

  • KPL closed at ₹3,745 on 6 Oct 2026, +2.77% on the day.
  • Delivery was 54.9% of traded quantity on 6 Oct 2026, the 78th percentile of its own 117 sessions with a reading (20-session average 40.7%, 1-year average 47.3%).
  • Market capitalisation is ₹3,886 crore, with no positive trailing earnings for a P/E.